• The treatment uses autologous cell transplantation technology where specific cells isolated from the hair follicles are taken from the scalp, cultured, and then implanted into the balding area to stimulate residing hair follicles and promote new hair growth.
  • The Tokyo-based company has worked on hair research since it was formed in 1872, producing a number of tonics and oils, using its origin in pharmacology as an advantage. It has also been promoting scalp and hair biology research from genetic and cellular levels for several years.
  • “Shiseido has a long history of conducting comprehensive research and working towards commercialization of the regenerative medicine for hair,” the company noted in a statement.

Share This Article